Clinical Trial Update: A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A multicenter Phase I-II study evaluated the combination of bendamustine with weekly paclitaxel as first- or second-line therapy in metastatic breast cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxol (paclitaxel)
• Treanda (Bendamustine)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Metastatic Breast Cancer | Phase 1 | Status: COMPLETED